Clinical Trial Update: Open-Label Creatine Study for Female Meth Users [NA]

View source ↗

Summary

Open-label creatine study in female meth users was terminated and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Methamphetamine Use Disorder
• Substance Use Disorder

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Perry Renshaw | Conditions: Depression, Dual Diagnosis | NA | Status: TERMINATED | Results posted: 2016-05-20